Acute respiratory distress syndrome (ARDS) after pressurized intraperitoneal aerosol chemotherapy with oxaliplatin: a case report

Pressurized intraperitoneal aerosol chemotherapy (PIPAC) is a new drug delivery method for intraabdominal cavity chemotherapy. It combines the benefits of a minimally invasive approach (low morbidity and easy to repeat) with the pharmacokinetic advantages of intraperitoneal administration and tolera...

Descripción completa

Detalles Bibliográficos
Autores principales: Thibaudeau, Emilie, Brianchon, Corinne, Raoul, Jean-Luc, Dumont, Frédéric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: De Gruyter 2021
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8719447/
https://www.ncbi.nlm.nih.gov/pubmed/35071738
http://dx.doi.org/10.1515/pp-2021-0126
_version_ 1784624938170187776
author Thibaudeau, Emilie
Brianchon, Corinne
Raoul, Jean-Luc
Dumont, Frédéric
author_facet Thibaudeau, Emilie
Brianchon, Corinne
Raoul, Jean-Luc
Dumont, Frédéric
author_sort Thibaudeau, Emilie
collection PubMed
description Pressurized intraperitoneal aerosol chemotherapy (PIPAC) is a new drug delivery method for intraabdominal cavity chemotherapy. It combines the benefits of a minimally invasive approach (low morbidity and easy to repeat) with the pharmacokinetic advantages of intraperitoneal administration and tolerance seems excellent. We would like to report one case of a serious adverse event, acute respiratory distress syndrome, which is likely related to oxaliplatin administration; all signs disappeared within a few days.
format Online
Article
Text
id pubmed-8719447
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher De Gruyter
record_format MEDLINE/PubMed
spelling pubmed-87194472022-01-20 Acute respiratory distress syndrome (ARDS) after pressurized intraperitoneal aerosol chemotherapy with oxaliplatin: a case report Thibaudeau, Emilie Brianchon, Corinne Raoul, Jean-Luc Dumont, Frédéric Pleura Peritoneum Short Communication Pressurized intraperitoneal aerosol chemotherapy (PIPAC) is a new drug delivery method for intraabdominal cavity chemotherapy. It combines the benefits of a minimally invasive approach (low morbidity and easy to repeat) with the pharmacokinetic advantages of intraperitoneal administration and tolerance seems excellent. We would like to report one case of a serious adverse event, acute respiratory distress syndrome, which is likely related to oxaliplatin administration; all signs disappeared within a few days. De Gruyter 2021-10-05 /pmc/articles/PMC8719447/ /pubmed/35071738 http://dx.doi.org/10.1515/pp-2021-0126 Text en © 2021 Emilie Thibaudeau et al., published by De Gruyter, Berlin/Boston https://creativecommons.org/licenses/by/4.0/This work is licensed under the Creative Commons Attribution 4.0 International License.
spellingShingle Short Communication
Thibaudeau, Emilie
Brianchon, Corinne
Raoul, Jean-Luc
Dumont, Frédéric
Acute respiratory distress syndrome (ARDS) after pressurized intraperitoneal aerosol chemotherapy with oxaliplatin: a case report
title Acute respiratory distress syndrome (ARDS) after pressurized intraperitoneal aerosol chemotherapy with oxaliplatin: a case report
title_full Acute respiratory distress syndrome (ARDS) after pressurized intraperitoneal aerosol chemotherapy with oxaliplatin: a case report
title_fullStr Acute respiratory distress syndrome (ARDS) after pressurized intraperitoneal aerosol chemotherapy with oxaliplatin: a case report
title_full_unstemmed Acute respiratory distress syndrome (ARDS) after pressurized intraperitoneal aerosol chemotherapy with oxaliplatin: a case report
title_short Acute respiratory distress syndrome (ARDS) after pressurized intraperitoneal aerosol chemotherapy with oxaliplatin: a case report
title_sort acute respiratory distress syndrome (ards) after pressurized intraperitoneal aerosol chemotherapy with oxaliplatin: a case report
topic Short Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8719447/
https://www.ncbi.nlm.nih.gov/pubmed/35071738
http://dx.doi.org/10.1515/pp-2021-0126
work_keys_str_mv AT thibaudeauemilie acuterespiratorydistresssyndromeardsafterpressurizedintraperitonealaerosolchemotherapywithoxaliplatinacasereport
AT brianchoncorinne acuterespiratorydistresssyndromeardsafterpressurizedintraperitonealaerosolchemotherapywithoxaliplatinacasereport
AT raouljeanluc acuterespiratorydistresssyndromeardsafterpressurizedintraperitonealaerosolchemotherapywithoxaliplatinacasereport
AT dumontfrederic acuterespiratorydistresssyndromeardsafterpressurizedintraperitonealaerosolchemotherapywithoxaliplatinacasereport

Ejemplares similares